来曲唑联合替西罗莫司作为一线内分泌治疗绝经后晚期乳腺癌的随机Ⅲ期安慰剂对照研究
Randomized Phase Ⅲ Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus as First-Line Endocrine Therapy in Postmenopausal Women with Locally Advanced or Metastatic Breast Cancer
摘要1 文献来源Wolff AC,Lazar AA,Bondarenko I,et al.Randomized phase Ⅲ placebo-controlled trial of Letrozole plus oral Temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer [J].J Clin Oncol,2013,31(2):195-202.
更多相关知识
- 浏览192
- 被引2
- 下载61

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文